MedPath

Menthol and Mint Experimental Tobacco Marketplace (ETM) Study

Not Applicable
Completed
Conditions
Cigarette Smoking
Vaping
Interventions
Behavioral: All e-liquid flavors
Behavioral: Mint, Menthol and Tobacco e-liquids
Behavioral: Menthol and Tobacco e-liquids
Behavioral: Tobacco e-liquids
Registration Number
NCT04879225
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge of tobacco regulation is weighing the risks and benefits of potential policies across different populations (i.e., users and non-users). Tension arises between policies intended to prevent adolescent and young adult (AYA) tobacco initiation and those intended to reduce harm among current tobacco users. The availability of menthol e-liquids may be important for encouraging menthol cigarette smokers to switch to e- cigarettes, but mint e-liquids, which are appealing to AYA, may be unnecessary to facilitate switching. Including mint e-liquids in flavor bans but allowing menthol e-liquids to remain on the market as potential substitution products for menthol smokers may be an optimal policy approach. The study team is proposing a lab study and field assessment to determine how including menthol and mint e-liquids in e-liquid flavor bans or sales restrictions affects tobacco product purchasing and use among menthol cigarette smokers. At lab sessions, participants will complete the Experimental Tobacco Marketplace (ETM) task, a behavioral economics task in which they receive account balances to an online store and can buy menthol cigarettes at escalating costs or buy e-liquids, non-menthol cigarettes, or nicotine replacement gum at fixed costs. They will complete the task under four marketplace conditions: (1) only tobacco e-liquids available, (2) menthol and tobacco e-liquids available, (3) menthol, mint, and tobacco e-liquids available, and (4) tobacco, menthol, mint, fruit, dessert. During a field assessment, product choice is validated by assessing use of products purchased during the ETM task. This proposal will inform policy-makers about the impact banning menthol and mint e-liquids will have on facilitating menthol cigarette smokers switching to e-cigarettes.

Detailed Description

The study team proposes to conduct a within-subjects, multi-session virtual lab study and validation field assessment to determine how the availability of menthol and mint e-liquids affects product purchasing among menthol cigarette smokers. Adult daily menthol cigarette smokers will be recruited for this study. After initial eligibility is assessed, participants will complete six virtual sessions and one field assessment to evaluate their tobacco use.

Participants will be recruited from Winston-Salem, North Carolina (NC) and the surrounding area using advertisements on public transit, community flyers, and social media. Curbside visits to drop off biosamples and pickup study products will be conducted outside the Wake Forest Tobacco Control Center of Excellence located in Biotech Place in the Innovation Quarter.

The study team anticipates recruiting up to 100 participants to achieve 80 completers. Equal numbers of black and white participants will be enrolled.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  1. 21+ years of age
  2. Self-report smoking at least 5 cigarettes per day for the past year
  3. Self-report smoking menthol cigarette brands > 80% of the time
  4. Breathe carbon monoxide (CO) level > 8 ppm Willingness to use other tobacco products during the study
  5. Speak, comprehend, and read English sufficiently to complete study procedures
  6. Have home access to a computer or tablet with a web camera and internet access
Read More
Exclusion Criteria
  1. Currently seeking treatment to quit smoking
  2. Self-reported serious medical or psychiatric condition(s) including cardiovascular and chronic respiratory diseases
  3. Body temperature > 100.4 F
  4. Cold, flu or Novel Coronavirus (COVID-19) symptoms including fever, cough, and runny nose in the past 30 days
  5. Currently pregnant, breastfeeding or intending to become pregnant for the duration of the study or unwilling to agree to use adequate protection to avoid pregnancy
  6. CO reading > 80 ppm
  7. Enrollment stratum (Non-Hispanic, white or Black/African American)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Intervention 1: Fruit, dessert, mint, menthol, tobaccoAll e-liquid flavorsAll participants receive all interventional e-liquid flavors on separate days.
Intervention 2: Mint, menthol, and tobaccoMint, Menthol and Tobacco e-liquidsAll participants receive all interventional e-liquid flavors on separate days.
Intervention 3: Menthol and TobaccoMenthol and Tobacco e-liquidsAll participants receive all interventional e-liquid flavors on separate days.
Intervention 4: Only tobaccoTobacco e-liquidsAll participants receive all interventional e-liquid flavors on separate days.
Primary Outcome Measures
NameTimeMethod
Total Amount of Combusted Tobacco PurchasedDay 6

Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

Secondary Outcome Measures
NameTimeMethod
Total Amount of E-liquid PurchasedDay 3, Day 4, Day 5, Day 6

Total amount of e-liquid purchased when menthol cigarettes are not available.

Trial Locations

Locations (1)

Wake Forest Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath